PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26503559-4	2015	Treatment of human prostate cancer cells (LNCaP and PC-3) with UA inhibited the proliferation and induced apoptosis in both cell lines as characterized by the increased Annexin V-binding.	ursolic acid	63-65	annexin A5	Homo sapiens	169-178	
25230943-8	2015	Apoptosis was considerably increased by UA, indicated by enhancement of an Annexin-V positive population and a sub-G1 peak.	ursolic acid	40-42	annexin A5	Homo sapiens	75-84	
25383044-12	2014	Annexin V/PI staining suggested that UA induced both early and late phases of apoptosis.	ursolic acid	37-39	annexin A5	Homo sapiens	0-9	
21826595-5	2011	After SW480 cells were treated by UA at the concentrations of 0-40 mumol/L for 48 h, FCM showed that annexin V (AV) positive cells and hypodiploid peak ratio increased along with the increase in the drug"s concentrations; and Western blot found that expressions of Bcl-2, Bcl-xL and survivin decreased in a concentration-dependent manner.	ursolic acid	34-36	annexin A5	Homo sapiens	101-110	
20146252-4	2010	We found that UA treatment in vitro can effectively inhibit PC-3 cell viability in a dose-dependent manner by inducing apoptosis, demonstrated by annexin V-FITC/propidium iodide staining.	ursolic acid	14-16	annexin A5	Homo sapiens	146-155